AAV vectors

Showing 2 posts of 2 posts found.


Astellas and 4D Molecular Therapeutics enter license agreement for rare ophthalmic targets

July 11, 2023
Research and Development 4D Molecular Therapeutics, AAV vectors, Astellas Pharma, Opthalmology, ophthalmology

Astellas Pharma and 4D Molecular Therapeutics (4DMT) have announced a license agreement under which Astellas has the right to use …

Sanofi and SIRION collaborate on AAV vector development to treat serious diseases

February 24, 2021
Research and Development AAV vectors, SIRION, Sanofi

SIRION Biotech and Sanofi have entered into an agreement to develop effective medicines for illnesses impacting major human organs.

Latest content